Advertisement
Research ArticleENDOCRINE AND DIABETES

Novel Glucagon-Like Peptide-1 (GLP-1) Analog (Val8)GLP-1 Results in Significant Improvements of Glucose Tolerance and Pancreatic β-Cell Function after 3-Week Daily Administration in Obese Diabetic (ob/ob) Mice

Brian D. Green, Kerry S. Lavery, Nigel Irwin, Finbarr P. M. O'Harte, Patrick Harriott, Brett Greer, Clifford J. Bailey and Peter R. Flatt
Journal of Pharmacology and Experimental Therapeutics August 2006, 318 (2) 914-921; DOI: https://doi.org/10.1124/jpet.105.097824
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleENDOCRINE AND DIABETES

Novel Glucagon-Like Peptide-1 (GLP-1) Analog (Val8)GLP-1 Results in Significant Improvements of Glucose Tolerance and Pancreatic β-Cell Function after 3-Week Daily Administration in Obese Diabetic (ob/ob) Mice

Brian D. Green, Kerry S. Lavery, Nigel Irwin, Finbarr P. M. O'Harte, Patrick Harriott, Brett Greer, Clifford J. Bailey and Peter R. Flatt
Journal of Pharmacology and Experimental Therapeutics August 1, 2006, 318 (2) 914-921; DOI: https://doi.org/10.1124/jpet.105.097824
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement